Follow Us      

Share Page:

Volume 33 , Issue 5
September/October 2013

Pages 567573

A Clinical Investigation of Demineralized Bone Matrix Putty for Treatment of Periodontal Bony Defects in Humans

Arwa Ahmed Banjar, BDS, MS/Brian L. Mealey, DDS, MS

PMID: 23998152
DOI: 10.11607/prd.1745

The goal of this study was to evaluate the effectiveness of demineralized bone matrix (DBM) putty, consisting of demineralized human bone allograft matrix in a carrier of bovine collagen and alginate, for the treatment of periodontal defects in humans. Twenty subjects with at least one site having a probing depth ≥ 6 mm and radiographic evidence of bony defect depth > 3 mm were included. The infrabony defects were grafted with DBM putty bone graft. The following clinical parameters were assessed at baseline and 6 months posttreatment: probing depth (PD), gingival recession (GR), and clinical attachment level (CAL). Bone fill was evaluated using transgingival probing and standardized radiographs taken at baseline and 6 months posttreatment. The 6-month evaluation showed a significant PD reduction of 3.27 1.67 mm and clinical attachment gain of 2.27 1.74 mm. Bone sounding measurements showed a mean clinical bone defect fill of 2.93 1.87 mm and a mean radiographic bone fill of 2.55 2.31 mm. The use of DBM putty was effective for treatment of periodontal bony defects in humans. Significant improvement in CAL, PD, and bone fill was observed at 6 months compared to baseline. (Int J Periodontics Restorative Dent 2013;33:567573. doi: 10.11607/prd.1745)

Full Text PDF File | Order Article


Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.


© 2017 Quintessence Publishing Co, Inc

PRD Home
Current Issue
Ahead of Print
Author Guidelines
Accepted Manuscripts
Submission Form
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us